Streetbeat News

Equity Actions

NVAX

Novavax (NYSE:NVAX) has seen a 3.5% increase in short interest since its last report, with 50.91 million shares sold short, representing 51.47% of its float. It would take about 4.95 days to cover all short positions. High short interest can indicate bearish market sentiment but can also be bullish if it leads to a short squeeze. Novavax's short interest is significantly higher than its peer group average of 9.76%.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 8:30 pm

MRVL

Marvell Tech (NYSE:MRVL) has seen a 7.72% increase in short interest since its last report, with 20.48 million shares sold short, representing 2.79% of its float. The short interest is below the peer group average of 3.47%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 8:30 pm

JNPR

Juniper Networks (NYSE:JNPR) has seen a 26.28% decrease in short interest since its last report, with 12.84 million shares sold short, representing 5.33% of its float. The average time to cover these short positions is 1.0 day. Short interest is a market sentiment indicator, and Juniper's short interest is below its peer group average of 7.54%. While a decline in short interest does not necessarily predict a stock price increase, it indicates fewer shares are being shorted.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 8:15 pm

TSLA

A Delaware judge voided Elon Musk's 2018 compensation plan for Tesla, worth over $55 billion. Wedbush analyst Daniel Ives, who has an Outperform rating on Tesla with a price target of $315, called the situation a 'tornado' for Tesla's board. The board must decide whether to appeal, replace the package, or create a new one. Ives expects a statement from the board within 24 hours and believes a new compensation plan is needed to secure Musk's leadership through the EV and AI growth phase. Tesla shares were up 0.67% to $192.87 following the news.

Portfolio Pulse from Chris Katje

January 31, 2024 | 7:49 pm

BLNK

Blink Charging (NYSE:BLNK) has seen an 11.2% increase in short interest since the last report, with 22.25 million shares sold short, representing 37.74% of available shares. The short interest is above the peer group average of 7.72%. High short interest can indicate bearish market sentiment but can also lead to bullish outcomes in certain scenarios.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 7:45 pm

VERA

Vera Therapeutics (NYSE:VERA) has seen a decrease in short interest, with 6.05 million shares sold short, representing 17.98% of its float. The short interest has fallen by 3.75% since the last report, and it would take about 7.98 days to cover all short positions. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term price rise. Vera Therapeutics has a higher short interest compared to its peer group average of 11.66%.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 7:45 pm

VLO

Valero Energy (NYSE:VLO) has seen a decrease in short interest, with the short percent of float falling 6.79% since the last report. The company has 8.96 million shares sold short, representing 3.02% of available shares. The average time to cover these short positions is 3.27 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Valero has a lower short interest compared to its peer group average of 8.56%.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 7:45 pm

MTCH

Match Group's stock is up following the release of their Q4 financial results, which exceeded expectations. Additionally, the company has announced a $1 billion share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 7:43 pm

ASH

GNPX

MINM

NVVE

NYCB

POWL

U.S. stocks closed lower with the Dow down 0.21%, NASDAQ falling 1.53%, and S&P 500 dropping 1.02%. The Federal Reserve kept interest rates unchanged, which was expected. Ashland Inc. (ASH) surged 17% after mixed Q1 results and guidance. Minim, Inc. (MINM) jumped 65% due to a significant stake disclosure. Powell Industries (POWL) gained 48% on strong Q1 results and dividend raise. Nuvve Holding (NVVE) plunged 59% after pricing a public offering. New York Community Bancorp (NYCB) fell 36% on poor Q4 results and dividend cut. Genprex (GNPX) dropped 29% after announcing a reverse stock split.

Portfolio Pulse from Avi Kapoor

January 31, 2024 | 7:26 pm

PFE

Pfizer (NYSE:PFE) has received mixed analyst ratings over the past three months, with 8 analysts offering varied opinions. The average 12-month price target is $41.25, up 12.49% from the previous $36.67. Analysts from firms including Cantor Fitzgerald, TD Cowen, Truist Securities, UBS, and Barclays have maintained or lowered their price targets, with ratings ranging from 'Overweight' to 'Neutral'. Pfizer's financials show a revenue decline of -41.55% as of September 30, 2023, a net margin of -18.0%, ROE of -2.43%, ROA of -1.09%, and a debt-to-equity ratio of 0.66.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 7:00 pm